1Yamamoto Y. Ibusuki M, Kawasoe T. Basal cell-like signature is an independent prognostic factor in triple-negative breast cancer [J]. J Clin Oncol. 2008.26(suppl) : 22184
2Tohfe MA, Chamsedine N, Ghandour F. Triple-negative phenotype of breast cancer and its association with poor prognostic factors [J]. J Clin Oncol,2008,26(suppl):22134
3Haffty BG,Yang Q,Reiss M.et al. Locoregional and distant metastasis in conservatively managed triple negative early-stage breast cancer[J]. J Clin Oncol,2006,24(3) :5652-565
4Khan AM. Sabnani I. Tsang P. Triple-negative early- stage breast cancer in African American women:A fuel to the fire[J]. J Clin Oncol.2008.26(suppl) : 1039
5Choi MY, Lee KE,Chang HJ. Prognostic significance of triple- negative phenotype in breast cancer[J ]. J Clin Oncol, 2008,26 (suppl) : 11587
6Dent R,Trudeau M, Pritchard KI,et al. TN Breast Cancer:Clinical Features and Patterns of Recurrence[J]. Clin Cancer Res, 2007.13 (2) :4429-4434
7Palmieri D. Brain metastases of breast cancer[J]. Breast Dis,2007, 26(3):139-147
8Carey LA. Dees EC .Sawyer LR .et al. The triple negative paradox: Primary tumor chemosensitivity of the basal- like breast cancer phenotype[J]. Breast Cancer Res Treat,2004,80(4):1023
9Rouzier R, Perou CM, Symmans WF, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy[J]. Clin Cancer Res. 2005,11 (4) : 5678-5685
10Liedtke C,Mazouni C,Hess KR,et al. Response and Outcome After Neoadjuvant Therapy in Patients with Triple Negative vs. non -TN Breast cancer[J]. J Clin Oncol,2008,26(1 ) : 1275-1281
